These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17049126)

  • 1. Granulocyte-macrophage colony-stimulating factor DNA prime-protein boost strategy to enhance efficacy of a recombinant pertussis DNA vaccine.
    Li QT; Zhu YZ; Chu JY; Dong K; He P; Feng CY; Hu BY; Zhang SM; Guo XK
    Acta Pharmacol Sin; 2006 Nov; 27(11):1487-94. PubMed ID: 17049126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunity against Bordetella pertussis by a recombinant DNA vaccine and the effect of coinjection with a granulocyte-macrophage colony stimulating factor gene.
    Li Q; Zhu Y; Chu J; Wang Y; Xu Y; Hou Q; Zhang S; Guo X
    Microbiol Immunol; 2006; 50(12):929-36. PubMed ID: 17179660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the Cellular Immune Response to Recombinant Fragments of Filamentous Hemagglutinin and Pertactin of Bordetella pertussis in BALB/c Mice.
    Bakhshaei P; Kazemi MH; Golara M; Abdolmaleki S; Khosravi-Eghbal R; Khoshnoodi J; Judaki MA; Salimi V; Douraghi M; Jeddi-Tehrani M; Shokri F
    J Interferon Cytokine Res; 2018 Apr; 38(4):161-170. PubMed ID: 29638208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adults.
    He Q; Tran Minh NN; Edelman K; Viljanen MK; Arvilommi H; Mertsola J
    Infect Immun; 1998 Aug; 66(8):3796-801. PubMed ID: 9673264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and characterization of single-chain variable fragment antibodies directed against the Bordetella pertussis surface adhesins filamentous hemagglutinin and pertactin.
    Hussein AH; Davis EM; Halperin SA; Lee SF
    Infect Immun; 2007 Nov; 75(11):5476-82. PubMed ID: 17724067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Storage at -3 degrees C for 24 h alters the immunogenicity of pertussis vaccines.
    Boros CA; Hanlon M; Gold MS; Roberton DM
    Vaccine; 2001 May; 19(25-26):3537-42. PubMed ID: 11348721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a three-component acellular pertussis vaccine administered at birth.
    Belloni C; De Silvestri A; Tinelli C; Avanzini MA; Marconi M; Strano F; Rondini G; Chirico G
    Pediatrics; 2003 May; 111(5 Pt 1):1042-5. PubMed ID: 12728086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
    Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
    BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children.
    Podda A; Carapella De Luca E; Titone L; Casadei AM; Cascio A; Bartalini M; Volpini G; Peppoloni S; Marsili I; Nencioni L
    J Pediatr; 1993 Jul; 123(1):81-4. PubMed ID: 8320630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of chosen parameters of immuno response in mice immunized with whole-cell or acellular pertussis vaccines and challenged with B. pertussis strains harbouring different ptxS1/prn allele genes combinations].
    Gzyl A; Augustynowicz E; Zawadka M; Rabczenko D; Slusarczyk J
    Med Dosw Mikrobiol; 2007; 59(2):137-47. PubMed ID: 17929411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
    Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
    Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of recombinant and native pertactin of Bordetella pertussis.
    Xu Y; Zhang S; Bolgiano B; Tan Y; Asokanathan C; Zhang H; Xing D; Wang J
    Vaccine; 2011 Feb; 29(10):1974-80. PubMed ID: 21216309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.
    Cheung GY; Xing D; Prior S; Corbel MJ; Parton R; Coote JG
    Infect Immun; 2006 Dec; 74(12):6797-805. PubMed ID: 16982827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion expression and immunogenicity of Bordetella pertussis PTS1-FHA protein: implications for the vaccine development.
    Jinyong Z; Xiaoli Z; Weijun Z; Ying G; Gang G; Xuhu M; Quanming Z
    Mol Biol Rep; 2011 Mar; 38(3):1957-63. PubMed ID: 20878241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.
    Xu Z; Octavia S; Luu LDW; Payne M; Timms V; Tay CY; Keil AD; Sintchenko V; Guiso N; Lan R
    Emerg Infect Dis; 2019 Jun; 25(6):1196-1199. PubMed ID: 31107218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal and systemic immune responses elicited by recombinant Lactococcus lactis expressing a fusion protein composed of pertussis toxin and filamentous hemagglutinin from Bordetella pertussis.
    Torkashvand A; Bahrami F; Adib M; Ajdary S
    Microb Pathog; 2018 Jul; 120():155-160. PubMed ID: 29738814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine.
    Hegerle N; Dore G; Guiso N
    Vaccine; 2014 Nov; 32(49):6597-600. PubMed ID: 25312274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis.
    Xu Y; Wang Y; Tan Y; Zhang H; Wu L; Wang L; Hou Q; Zhang S
    BMC Microbiol; 2009 Dec; 9():274. PubMed ID: 20040101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
    Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
    Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of whole-cell and acellular pertussis vaccines effectiveness in clearance of experimental B. pertussis infection in mice].
    Gzyl A; Augustynowicz E; Zawadka M; Rabczenko D; Slusarczyk J
    Med Dosw Mikrobiol; 2007; 59(2):123-35. PubMed ID: 17929410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.